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Correction to: British Journal of Cancer (2003) 88, 613–623; doi: 10.1038/sj.bjc.66000681
Reference on p. 614 and in Table 2 (p. 615) to human
recombinant arginine decarboxylase is incorrect, as elsewhere in
the article. The enzyme was prepared by the overexpression of
biosynthetic arginine decarboxylase (speA), originating in Escher-
ichia coli and purified from E. coli TOP 10 as a fusion protein
(5xHis::speA) on a nickel-affinity column (Invitrogen).
We wish to apologise to Professor Stephen Boyle (Virginia
Polytechnic Institute & State University, Blackburg, VA, USA),
who kindly provided the enzyme for Cancer Treatments Interna-
tional, for this regrettable mistake.
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